Why it was recalled
Subpotent: Out of specification for assay at the 12-month time point.
Product description
Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16
Lot numbers, UPCs & expiration codes
Lots: BB70, BB71 Exp. May 2020
Where it was sold
Distributed Nationwide in the US
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0824-2020
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jan 14, 2020
- FDA report date
- Feb 5, 2020
- Quantity
- 6288 16 oz bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Pharmaceutical Associates Inc
Original FDA data
Every field from FDA enforcement report D-0824-2020, exactly as published.
Show all FDA fields
- City
- Greenville
- State
- SC
- Status
- Terminated
- Country
- United States
- Event ID
- 84712
- Address
- 1700 Perimeter Rd
- Code information
- Lots: BB70, BB71 Exp. May 2020
- Postal code
- 29605-5252
- Report date
- Feb 5, 2020
- Product type
- Drugs
- Recall number
- D-0824-2020
- Classification
- Class II
- Recalling firm
- Pharmaceutical Associates Inc
- Product quantity
- 6288 16 oz bottles
- Termination date
- Jun 3, 2021
- Reason for recall
- Subpotent: Out of specification for assay at the 12-month time point.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16
- Distribution pattern
- Distributed Nationwide in the US
- Recall initiation date
- Jan 14, 2020
- Initial firm notification
- Letter
- Center classification date
- Feb 3, 2020